Asset Details
Do you wish to reserve the book?
Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections
Do you wish to request the book?
Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections
2003
Overview
To draw up evidence-based guidelines to make injections safer.
A development group summarized evidence-based best practices for preventing injection-associated infections in resource-limited settings. The development process included a breakdown of the WHO reference definition of a safe injection into a list of potentially critical steps, a review of the literature for each of these steps, the formulation of best practices, and the submission of the draft document to peer review.
Eliminating unnecessary injections is the highest priority in preventing injection-associated infections. However, when intradermal, subcutaneous, or intramuscular injections are medically indicated, best infection control practices include the use of sterile injection equipment, the prevention of contamination of injection equipment and medication, the prevention of needle-stick injuries to the provider, and the prevention of access to used needles.
The availability of best infection control practices for intradermal, subcutaneous, and intramuscular injections will provide a reference for global efforts to achieve the goal of safe and appropriate use of injections. WHO will revise the best practices five years after initial development, i.e. in 2005.
Publisher
Organisation mondiale de la santé,World Health Organization,The World Health Organization
Subject
/ Biological and medical sciences
/ Cross Infection - prevention & control
/ Drugs
/ Equipment Contamination - prevention & control
/ Humans
/ Infection Control - standards
/ Injections - adverse effects
/ Injections, Intradermal/adverse effects
/ Injections, Intradermal/standards
/ Injections, Intramuscular/adverse effects
/ Injections, Intramuscular/standards
/ Injections, Subcutaneous/adverse effects
/ Injections, Subcutaneous/standards
/ Needles
/ Public health. Hygiene-occupational medicine
/ Syringes
